This study compared high dose ranitidine versus low dose omeprazole with antibiotics for the eradication of Hpylori. 80 patients (mean age 48 years, range 18-75) who had H pylori infection were randomised in an investigator-blind manner to either a two-week regime of omeprazole 20 mg daily, amoxycillin 500 mg tid and metronidazole 400 mg tid (OAM), or ranitidine 600 mg bd, amoxycillin 500 mg tid and metronidazole 400 mg tid (RAM), or omeprazole 20 mg daily and clarithromycin 500 mg tid (OC), or omeprazole 20 mg daily and placebo (OP). H pylori was eradicated in 6 of 19 patients in the OAM group (32%); 8 of 18 in the RAM group (44%), 4 of 15 in the OC group (27%); none of 18 in the OP group (0%). [<PO.005 for OAM, RAM, OC vs OP; P=N. S. between OAM, RAM, OC]. Overall metronidazole resistance was unexpectedly high at 58%. Eradication rates in metronidazole sensitive patients were 71% (5/7) and 100% (3/3) for OAM and RAM respectively. In conclusion, H pylori eradication rates using high dose ranitidine plus amoxycillin and metronidazole may be similar to that of low dose omeprazole in combination with the same antibiotics or omeprazole with clarithromycin. Overall eradication rates were low due to a high incidence of metronidazole resistance but were higher in metronidazole-sensitive patients. Even high dose ranitidine with two antibiotics achieves a relatively low eradication rate. These metronidazole-based regimens cannot be recommended in areas with a high incidence of metronidazole resistance.
INTRODUCTION
Helicobacter pylori infection is found in most patients suffering from chronic active gastritis or peptic ulceration.' Eradication of H pylori prevents relapses of duodenal ulcer'"2 and probably lessens the risk of ulcer complications.36 The optimal therapeutic regimen for eradicating Hpylori is not yet determined. Numerous studies have evaluated the combination of a proton pump inhibitor, omeprazole, with a single or double antibiotic regimen such as amoxycillin or clarithromycin, reporting eradication rates of around 80O%. -9 In contrast, fewer studies have evaluated the role of histamine-2 receptor antagonists when combined with antibiotics.
Hentschel et al'°found that ranitidine in combination with amoxycillin plus metronidazole produced an eradication rate of 89%. Ranitidine 
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The Ulster Medical Journal combined with triple therapy (bismuth, metronidazole and tetracycline) produced an eradication rate of 84%.1" Thus ranitidine in combination with antibiotics may be as effective as omeprazole plus antibiotics in the eradication of H pylori. However few randomised studies have compared ranitidine and antibiotics with omeprazole and antibiotics in the eradication of H pylori. The aims of our study were to evaluate the efficacy ofHpylori eradication using ranitidine compared to omeprazole when they are combined with antibiotics. The antibiotics used were amoxycillin and metronidazole to produce a triple therapy regimen without bismuth, as there is some evidence that the addition of bismuth is not necessary in achieving high eradication rates with this type of triple therapy.'0 These two regimens were compared to a control regimen of omeprazole alone and the regimen of omeprazole plus clarithromycin which has been associated with high eradication rates.
METHODS
The study was had diarrhoea but continued with the study. Two (10%) of the patients in the RAM group complained of nausea and vomiting and they both withdrew from the study. Two (10%) of the patients in the OP group complained of diarrhoea, one of whom withdrew from the study. Three (15%) of the patients in the OC group complained of diarrhoea (one) and vomiting (two); they all withdrew from the study. In total, 11 % of patients suffered from side-effects and of these 9% withdrew from the study as a result.
Compliance was good in all the groups (>90% consumption of the delivered study medication) with no significant differences between them except for two patients who withdrew from the study because of poor compliance in the OC group. The eradication rates achieved in this study were low compared to some previous similar studies. The eradication rates of ranitidine 1200 mg with amoxycillin plus metronidazole, and omeprazole 20 mg with the same antibiotics were 44% and 32% respectively. One group has found that the combination of omeprazole 40 mg daily with amoxycillin and metronidazole for 14 days gave an overall eradication rate of 91% but only 47%
with metronidazole-resistant strains.20 As the majority of our patients had metronidazole resistance, our results are similar to this group's eradication rates in those with metronidazole resistance. The only previous controlled randomised trial using ranitidine 300 mg daily in combination with amoxycillin and metronidazole for 10 days achieved an eradication rate of 89% which is comparable to that of bismuth triple therapy.10 However their incidence of metronidazole resistance was low (11 %) which could explain why they achieved higher eradication rates than us. Our eradication rate with omeprazole 20 
